The ACME Laboratories Ltd. (DSE:ACMELAB)

The ACME Laboratories Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1,860	1,927	1,752	1,455	1,239	1,594
Short-Term Investments	1,184	114.92	56.32	50.45	48.14	180.12
Cash & Short-Term Investments	3,044	2,042	1,808	1,506	1,287	1,774
Cash Growth	6.75%	12.95%	20.09%	17.00%	-27.45%	-15.60%
Accounts Receivable	3,650	3,614	3,259	2,705	2,236	2,216
Other Receivables	120.11	120.52	20.13	19.89	19.81	19.93
Receivables	3,771	3,734	3,279	2,725	2,256	2,236
Inventory	12,269	12,588	11,871	10,234	7,879	5,124
Prepaid Expenses	11.77	23.54	17.36	15.61	14.01	13.09
Other Current Assets	6,464	7,126	6,886	6,655	5,907	6,193
Total Current Assets	25,559	25,515	23,863	21,136	17,343	15,341
Property, Plant & Equipment	33,361	32,849	31,729	29,243	25,599	25,100
Long-Term Investments	31.48	30.38	30.2	31.52	32.88	35.51
Other Intangible Assets	57.81	-	-	-	0	0.02
Total Assets	59,009	58,394	55,622	50,410	42,975	40,476
Accounts Payable	508.28	514.07	603.67	490.89	449	350.25
Accrued Expenses	706.76	481.93	600.01	553.26	574.63	508.59
Short-Term Debt	14,843	15,612	15,053	12,523	9,383	7,141
Current Portion of Long-Term Debt	2,021	2,123	2,115	2,054	2,328	2,601
Current Portion of Leases	24.24	27.86	21.49	21.86	22.33	14.27
Current Income Taxes Payable	3,554	3,276	3,022	3,255	2,661	2,856
Current Unearned Revenue	-	64.32	111.83	48.2	14.46	8.33
Other Current Liabilities	3.76	3.8	3.83	6.51	4.38	7.23
Total Current Liabilities	21,660	22,104	21,531	18,953	15,438	13,487
Long-Term Debt	7,466	7,075	6,753	6,168	4,175	5,442
Long-Term Leases	74.73	77.4	44.87	62.29	73.2	62.88
Pension & Post-Retirement Benefits	1,700	1,630	1,451	1,028	691.75	500.46
Long-Term Deferred Tax Liabilities	730.96	767.68	790.57	903.14	907.59	873.54
Total Liabilities	31,632	31,654	30,570	27,115	21,285	20,366
Common Stock	2,116	2,116	2,116	2,116	2,116	2,116
Additional Paid-In Capital	5,128	5,128	5,128	5,128	5,128	5,128
Retained Earnings	15,214	14,567	12,833	11,029	9,304	7,675
Comprehensive Income & Other	4,920	4,930	4,975	5,022	5,142	5,192
Shareholders' Equity	27,377	26,740	25,052	23,295	21,690	20,111
Total Liabilities & Equity	59,009	58,394	55,622	50,410	42,975	40,476
Total Debt	24,428	24,915	23,988	20,829	15,982	15,262
Net Cash (Debt)	-21,384	-22,873	-22,179	-19,324	-14,694	-13,488
Net Cash Per Share	-101.06	-108.09	-104.82	-91.32	-69.44	-63.74
Filing Date Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Total Common Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Working Capital	3,899	3,411	2,332	2,182	1,905	1,853
Book Value Per Share	129.38	126.37	118.39	110.09	102.50	95.04
Tangible Book Value	27,319	26,740	25,052	23,295	21,690	20,111
Tangible Book Value Per Share	129.11	126.37	118.39	110.09	102.50	95.04
Land	-	5,547	5,419	5,233	5,228	4,967
Buildings	-	14,306	12,236	9,649	8,112	6,770
Machinery	-	16,687	17,346	16,538	13,018	12,934
Construction In Progress	-	3,195	3,756	4,367	4,820	5,442

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.